Thermo Fisher Scientific (TMO) : First National Bank Of Omaha reduced its stake in Thermo Fisher Scientific by 1.08% during the most recent quarter end. The investment management company now holds a total of 49,946 shares of Thermo Fisher Scientific which is valued at $7,736,635 after selling 545 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on Oct 12, 2016.Thermo Fisher Scientific makes up approximately 0.61% of First National Bank Of Omaha’s portfolio.
Other Hedge Funds, Including , Nisa Investment Advisors reduced its stake in TMO by selling 50 shares or 0.03% in the most recent quarter. The Hedge Fund company now holds 150,133 shares of TMO which is valued at $23,255,602. Thermo Fisher Scientific makes up approx 0.31% of Nisa Investment Advisors’s portfolio.Raymond James Trust N.a. boosted its stake in TMO in the latest quarter, The investment management firm added 129 additional shares and now holds a total of 5,958 shares of Thermo Fisher Scientific which is valued at $947,977. Thermo Fisher Scientific makes up approx 0.08% of Raymond James Trust N.a.’s portfolio.First Mercantile Trust Co reduced its stake in TMO by selling 695 shares or 20.44% in the most recent quarter. The Hedge Fund company now holds 2,705 shares of TMO which is valued at $427,958. Thermo Fisher Scientific makes up approx 0.06% of First Mercantile Trust Co’s portfolio.Exxonmobil Investment Management Inc Tx reduced its stake in TMO by selling 1,192 shares or 1.17% in the most recent quarter. The Hedge Fund company now holds 100,669 shares of TMO which is valued at $15,926,842. Thermo Fisher Scientific makes up approx 0.33% of Exxonmobil Investment Management Inc Tx’s portfolio.First American Trust Fsb reduced its stake in TMO by selling 6,910 shares or 37.34% in the most recent quarter. The Hedge Fund company now holds 11,598 shares of TMO which is valued at $1,835,731. Thermo Fisher Scientific makes up approx 0.58% of First American Trust Fsb’s portfolio.
Thermo Fisher Scientific closed down -4.21 points or -2.65% at $154.9 with 26,97,528 shares getting traded on Tuesday. Post opening the session at $156, the shares hit an intraday low of $153.79 and an intraday high of $156.585 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $2.01. The company had revenue of $4535.20 million for the quarter, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. JP Morgan Resumed Thermo Fisher Scientific on Sep 22, 2016 to “Overweight”, Price Target of the shares are set at $180.Thermo Fisher Scientific was Downgraded by Cleveland Research to ” Neutral” on Sep 9, 2016.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.